ABclonal is a biotechnology company that is a supplier of global antibody and molecular enzyme reagents.
ABclonal Technology is a rapidly growing life science research and diagnostic reagents provider. With scientists from world-class universities, the company thrives on improving the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS library preparation kits and molecular enzymes.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2021 | Series D | ¥1.20B | 2 | — | — | Detail |
Feb 22, 2021 | Series C | $93M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Taikang Touzi | — | Series D |
Zhengxingu Capital | — | Series D |
Kinghall Ventures | — | Series C |
Sigma Square Capital | — | Series C |